KALB MICHAEL WAYNE (Executive Vice President & CFO) exercised options at CATALYST PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/6/2026ACC: 0001161697-26-000022
Officer· Executive Vice President & CFO
Since Jan 2024
-2.08K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
7.14K acquired · 9.22K disposed
Non-Derivative Transactions2
Common Stock, par value $0.001 per share
Direct
Shares
+7.14K
Price / share
—
Trade value
—
% of position
83.0%
1/5/2026
8.61K→15.74K
Common Stock, par value $0.001 per share
Direct
Shares
−2.08K
Price / share
—
Trade value
—
% of position
13.2%
1/5/2026
15.74K→13.66K
Total
Net shares
+5.06K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Direct | 1/5/2026 | M · Option Exercise | +7.14K | — | — | 83.0% | 8.61K | 15.74K |
| Common Stock, par value $0.001 per share Direct | 1/5/2026 | F · Tax Withholding | −2.08K | — | — | 13.2% | 15.74K | 13.66K |
| Total | +5.06K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
7.14K shares
Shares
−7.14K
Strike price
Held after
632.90K
Exercisable
—
1/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock7.14K shares | 1/5/2026 | M · Option Exercise | −7.14K | — | 632.90K |